Delivery Order SPE2DB22D2211-SPE2DB25FRVPB

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,828.15 contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of April 17, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract is a firm fixed-price delivery order with a ceiling value of $13,013.30 and a performance period through April 8, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,526.26 contract is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,721.61, is for the supply of the diabetes medication Trulicity 0.75 mg/0.5 ml pen. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,702.70, is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a $14,531.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. The contract has a completion date of December 18, 2023 and was awarded on December 15, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $3,642.95 and is a firm fixed-price delivery order. The contract has an ultimate completion date of May 9, 2025. This appears to be part of a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract has a firm fixed price of $25,942.97 and a completion date of March 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $2,227.17. The order is for the medication Trulicity 1.5 mg/0.5 ml pen with a completion date of January 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical through November 2026. The IDC covers a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $1,501.50, is for the Trulicity 3 mg/0.5 ml pen 0.5 ml medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRVPB
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a diabetes medication. The contract has a firm fixed price of $3,967.20 and a completion date of April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and is open to full and open competition.

Generated 7/18/25, 10:08 AM